Results 201 to 210 of about 690,120 (348)

New insights into mitral valve dystrophy: a Filamin-A genotype–phenotype and outcome study

open access: yesEuropean Heart Journal, 2018
T. Le Tourneau   +29 more
semanticscholar   +1 more source

Circulating growth differentiation factor‐15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20‐year follow‐up study

open access: yesEuropean Journal of Heart Failure, EarlyView.
Summary of the study design and key findings. The (+) and (−) signs mean that the variable has a positive or a negative association with growth differentiation factor‐15 (GDF‐15) levels in the fully adjusted model (age, gender, current smoker, body mass index, total cholesterol, systolic blood pressure and N‐terminal pro‐B‐type natriuretic peptide ...
Luca Monzo   +11 more
wiley   +1 more source

Heterotransplantation of goat mitral valves in dogs

open access: bronze, 1967
GEOIIGE PAPPAS   +2 more
openalex   +1 more source

Cardiogenic shock requiring VA‐ECMO therapy in scorpionism‐induced myocarditis

open access: yes
ESC Heart Failure, EarlyView.
Alba I. Violino   +5 more
wiley   +1 more source

Cardioprotective effects of semaglutide on isolated human ventricular myocardium

open access: yesEuropean Journal of Heart Failure, EarlyView.
Semaglutide reduces late sodium current (INa) and diastolic calcium (Ca) sparks in human cardiomyocytes from aortic stenosis (AS) and end‐stage heart failure with reduced ejection fraction (HFrEF) patients, thereby increasing Ca transients. Improved Ca storage may underly the enhanced contractility of human cardiomyocytes upon semaglutide.
Thomas Krammer   +16 more
wiley   +1 more source

Rheumatic Mitral Valve Surgery: Repair or Replacement? [PDF]

open access: yesBraz J Cardiovasc Surg
Pereira LHO   +10 more
europepmc   +1 more source

Mitral Ball-Valve Prosthesis [PDF]

open access: bronze, 1964
Paul Kezdi, Louis R. Head, Bruce A. Buck
openalex   +1 more source

The use of left ventricular ejection fraction in the diagnosis and management of heart failure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS)

open access: yesEuropean Journal of Heart Failure, EarlyView.
Abstract This clinical consensus statement revisits the role of left ventricular ejection fraction (LVEF) as a measurement of cardiac function, a prognostic marker and a major criterion to classify patients with heart failure, and gives new advice for clinical practice.
Giuseppe M.C. Rosano   +20 more
wiley   +1 more source

A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides

open access: yesEuropean Journal of Heart Failure, EarlyView.
Applying a simplified left atrial/natriuretic peptide (LA/NP) approach by combining enlarged LA volume indexed for height2 or elevated (N‐terminal pro) B‐type natriuretic peptide [(NT‐pro)BNP], using different cut‐off values for sinus rhythm (SR) and atrial fibrillation (AF) history.
Jerremy Weerts   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy